Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 161

1.

Identifying postmenopausal women at high risk of fracture in populations: a comparison of three strategies.

Buist DS, LaCroix AZ, Manfredonia D, Abbott T.

J Am Geriatr Soc. 2002 Jun;50(6):1031-8.

PMID:
12110062
2.

Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men.

Siris ES, Baim S, Nattiv A.

Postgrad Med. 2010 Jan;122(1):82-90. doi: 10.3810/pgm.2010.01.2102. Review.

PMID:
20107292
3.

Identification of osteopenic women at high risk of fracture: the OFELY study.

Sornay-Rendu E, Munoz F, Garnero P, Duboeuf F, Delmas PD.

J Bone Miner Res. 2005 Oct;20(10):1813-9. Epub 2005 Jun 20.

4.

Recency and duration of postmenopausal hormone therapy: effects on bone mineral density and fracture risk in the National Osteoporosis Risk Assessment (NORA) study.

Barrett-Connor E, Wehren LE, Siris ES, Miller P, Chen YT, Abbott TA 3rd, Berger ML, Santora AC, Sherwood LM.

Menopause. 2003 Sep-Oct;10(5):412-9.

PMID:
14501602
5.
6.

Identification of women at increased risk of osteoporosis: no need to use different screening tools at different ages.

Dargent-Molina P, Piault S, Bréart G.

Maturitas. 2006 Apr 20;54(1):55-64. Epub 2005 Sep 30.

PMID:
16202546
7.

Bone mineral density thresholds for pharmacological intervention to prevent fractures.

Siris ES, Chen YT, Abbott TA, Barrett-Connor E, Miller PD, Wehren LE, Berger ML.

Arch Intern Med. 2004 May 24;164(10):1108-12.

PMID:
15159268
8.

Use of clinical risk factors in elderly women with low bone mineral density to identify women at higher risk of hip fracture: The EPIDOS prospective study.

Dargent-Molina P, Douchin MN, Cormier C, Meunier PJ, Bréart G; EPIDOS Study Group.

Osteoporos Int. 2002 Jul;13(7):593-9.

PMID:
12111021
9.

Low bone mineral density and fracture burden in postmenopausal women.

Cranney A, Jamal SA, Tsang JF, Josse RG, Leslie WD.

CMAJ. 2007 Sep 11;177(6):575-80.

10.

Instant vertebral assessment: a noninvasive dual X-ray absorptiometry technique to avoid misclassification and clinical mismanagement of osteoporosis.

Greenspan SL, von Stetten E, Emond SK, Jones L, Parker RA.

J Clin Densitom. 2001 Winter;4(4):373-80.

PMID:
11748342
11.

Screening for postmenopausal osteoporosis: a review of the evidence for the U.S. Preventive Services Task Force.

Nelson HD, Helfand M, Woolf SH, Allan JD.

Ann Intern Med. 2002 Sep 17;137(6):529-41.

PMID:
12230356
12.

Osteoporosis prevalence and levels of treatment in primary care: the Australian BoneCare Study.

Eisman J, Clapham S, Kehoe L; Australian BoneCare Study.

J Bone Miner Res. 2004 Dec;19(12):1969-75. Epub 2004 Sep 13.

13.

Use of a Swedish T-score reference population for women causes a two-fold increase in the amount of postmenopausal Swedish patients that fulfill the WHO criteria for osteoporosis.

Ribom EL, Ljunggren O, Mallmin H.

J Clin Densitom. 2008 Jul-Sep;11(3):404-11. doi: 10.1016/j.jocd.2007.12.014. Epub 2008 Feb 15.

PMID:
18280191
14.

Osteodensitometry in healthy postmenopausal women.

[No authors listed]

Prescrire Int. 2008 Apr;17(94):68-72.

PMID:
18536138
15.

Epidemiology, etiology, and diagnosis of osteoporosis.

Lane NE.

Am J Obstet Gynecol. 2006 Feb;194(2 Suppl):S3-11. Review.

PMID:
16448873
16.

Trends and determinants of antiresorptive drug use for osteoporosis among elderly women.

Perreault S, Dragomir A, Desgagné A, Blais L, Rossignol M, Blouin J, Moride Y, Ste-Marie LG, Fernandès JC.

Pharmacoepidemiol Drug Saf. 2005 Oct;14(10):685-95.

PMID:
15645517
17.

Health-economic comparison of three recommended drugs for the treatment of osteoporosis.

Brecht JG, Kruse HP, Möhrke W, Oestreich A, Huppertz E.

Int J Clin Pharmacol Res. 2004;24(1):1-10.

PMID:
15575171
18.

A prospective evaluation of bone mineral density measurement in females who have fallen.

Newton JL, Kenny RA, Frearson R, Francis RM.

Age Ageing. 2003 Sep;32(5):497-502.

PMID:
12957998
19.

Supplemental Content

Support Center